Dr. William Makis VS Canada

Dr. William Makis has published over 100 peer-reviewed articles in international medical journals, primarily focusing on nuclear medicine, targeted radionuclide therapy, and PET/CT imaging, including research on treatments like 177Lu-DOTATATE PRRT for neuroendocrine tumors.
He was involved in managing one of the largest single-institution phase II clinical trials for Lutathera (177Lu-DOTATATE) in North America, involving 250 neuroendocrine tumor patients.